Title : Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients.

Pub. Date : 2022 Apr

PMID : 35083882






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BNP levels decreased in 9/11 (82%) levosimendan treated patients, from a median of 1015 ng/L (261-1035) to 719 ng/L (294-739), (P < 0.01). Simendan natriuretic peptide B Homo sapiens
2 CONCLUSIONS: In this small-scale study of ambulatory advanced HF patients, we observed improvements in right ventricular systolic function, maximal O2 consumption, and BNP after switching from milrinone to levosimendan based IIT. Simendan natriuretic peptide B Homo sapiens